| 1 |
34325497 |
10.4143/crt.2021.752 |
2022 |
Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma. |
PIM1 |
| 2 |
34448823 |
10.1182/bloodadvances.2021004212 |
2022 |
The molecular hallmarks of primary and secondary vitreoretinal lymphoma. |
PIM1 |
| 3 |
34714908 |
10.1182/bloodadvances.2021005486 |
2022 |
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways. |
PIM1 |
| 4 |
35030632 |
10.1182/bloodadvances.2021006410 |
2022 |
Distinct clinical and genetic features of hepatitis B virus-associated follicular lymphoma in Chinese patients. |
PIM1 |
| 5 |
35106936 |
10.1002/cam4.4550 |
2022 |
SGK1 mutation status can further stratify patients with germinal center B-cell-like diffuse large B-cell lymphoma into different prognostic subgroups. |
PIM1 |
| 6 |
35223507 |
10.3389/fonc.2022.824632 |
2022 |
<i>PIM1</i> and <i>CD79B</i> Mutation Status Impacts the Outcome of Primary Diffuse Large B-Cell Lymphoma of the CNS. |
PIM1 |
| 7 |
35300216 |
10.2147/JIR.S341355 |
2022 |
The Mutation of <i>BTG2</i> Gene Predicts a Poor Outcome in Primary Testicular Diffuse Large B-Cell Lymphoma. |
PIM1 |
| 8 |
35401516 |
10.3389/fimmu.2022.842439 |
2022 |
Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma. |
PIM1 |
| 9 |
35646048 |
10.3389/fgene.2022.878618 |
2022 |
Whole-Genome/Exome Sequencing Uncovers Mutations and Copy Number Variations in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System. |
PIM1 |
| 10 |
35928872 |
10.3389/fonc.2022.932674 |
2022 |
Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma. |
PIM1 |
| 11 |
35937947 |
10.1155/2022/6441139 |
2022 |
Genomic Mutation Landscape of Primary Breast Lymphoma: Next-Generation Sequencing Analysis. |
PIM1 |
| 12 |
36081566 |
10.3389/fonc.2022.941347 |
2022 |
Molecular subtyping of CD5+ diffuse large B-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx. |
PIM1 |
| 13 |
32139889 |
10.1038/s41375-020-0766-4 |
2021 |
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL. |
PIM1 |
| 14 |
32973328 |
10.1038/s41379-020-00685-7 |
2021 |
The clinicopathological and molecular features of sinusoidal large B-cell lymphoma. |
PIM1 |
| 15 |
33202420 |
10.1182/blood.2020008520 |
2021 |
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity. |
PIM1 |
| 16 |
33479306 |
10.1038/s41598-020-80376-0 |
2021 |
Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma. |
PIM1 |
| 17 |
33581493 |
10.1016/j.ctarc.2021.100310 |
2021 |
Diversity of genetic alterations of primary central nervous system lymphoma in Hispanic versus non-Hispanic patients. |
PIM1 |
| 18 |
33747936 |
10.3389/fonc.2021.622648 |
2021 |
Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma. |
PIM1 |
| 19 |
33777778 |
10.3389/fonc.2021.628807 |
2021 |
Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma. |
PIM1 |
| 20 |
33945543 |
10.1371/journal.pone.0248886 |
2021 |
Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes. |
PIM1 |
| 21 |
34374220 |
10.1002/cjp2.223 |
2021 |
c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma. |
PIM1 |
| 22 |
34925435 |
10.3389/fgene.2021.677650 |
2021 |
Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing. |
PIM1 |
| 23 |
34944954 |
10.3390/cancers13246334 |
2021 |
Impact of a Faulty Germinal Center Reaction on the Pathogenesis of Primary Diffuse Large B Cell Lymphoma of the Central Nervous System. |
PIM1 |
| 24 |
35116576 |
10.21037/tcr-20-2525 |
2021 |
Identification of key mutations in central nervous diffuse large B-cell lymphoma (DLBCL) by comprehensive analysis between sequencing and TCGA database. |
PIM1 |
| 25 |
31886867 |
10.1093/jnen/nlz125 |
2020 |
Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma. |
PIM1 |
| 26 |
32201861 |
10.1093/noajnl/vdaa018 |
2020 |
Primary CNS lymphoma commonly expresses immune response biomarkers. |
PIM1 |
| 27 |
32239385 |
10.1007/s11523-020-00710-4 |
2020 |
Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib. |
PIM1 |
| 28 |
32399964 |
10.1002/ijc.33049 |
2020 |
Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroup. |
PIM1 |
| 29 |
32469082 |
10.1002/cncr.32866 |
2020 |
Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma. |
PIM1 |
| 30 |
32565964 |
10.3892/ol.2020.11552 |
2020 |
Comprehensive characterization of driver genes in diffuse large B cell lymphoma. |
PIM1 |
| 31 |
32864130 |
10.1186/s40364-020-00214-3 |
2020 |
A genetic predictive model for precision treatment of diffuse large B-cell lymphoma with early progression. |
PIM1 |
| 32 |
33252851 |
10.1002/ctm2.221 |
2020 |
Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma. |
PIM1 |
| 33 |
31403034 |
10.3389/fonc.2019.00683 |
2019 |
Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes. |
PIM1 |
| 34 |
31806993 |
10.2147/OTT.S227122 |
2019 |
Genomic Alterations In Primary Cardiac Diffuse Large B Cell Lymphoma: A Case Report And Literature Review. |
PIM1 |
| 35 |
29891112 |
10.1016/j.critrevonc.2018.05.010 |
2018 |
Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities. |
PIM1 |
| 36 |
29937999 |
10.18632/oncotarget.25463 |
2018 |
Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma. |
PIM1 |
| 37 |
30227305 |
10.1016/j.neo.2018.08.012 |
2018 |
Analysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes. |
PIM1 |
| 38 |
27641442 |
10.1016/j.bbadis.2016.09.012 |
2017 |
CD95-mediated apoptosis in Burkitt's lymphoma B-cells is associated with Pim-1 down-regulation. |
PIM1 |
| 39 |
28134252 |
10.1038/ncomms14290 |
2017 |
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors. |
PIM1 |
| 40 |
28368397 |
10.1038/onc.2017.90 |
2017 |
Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype. |
PIM1 |
| 41 |
28479318 |
10.1016/j.jid.2017.04.010 |
2017 |
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing. |
PIM1 |
| 42 |
28841204 |
10.1038/bcj.2017.72 |
2017 |
From Waldenström's macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation. |
PIM1 |
| 43 |
29245897 |
10.18632/oncotarget.18502 |
2017 |
Comparative analysis of primary <i>versus</i> relapse/refractory DLBCL identifies shifts in mutation spectrum. |
PIM1 |
| 44 |
29262531 |
10.18632/oncotarget.21986 |
2017 |
Mutational profile of primary breast diffuse large B-cell lymphoma. |
PIM1 |
| 45 |
26757737 |
10.1007/s00401-016-1536-2 |
2016 |
Genomic characterization of primary central nervous system lymphoma. |
PIM1 |
| 46 |
26773040 |
10.1182/blood-2015-09-672352 |
2016 |
Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease. |
PIM1 |
| 47 |
27030389 |
10.1182/blood-2015-12-686550 |
2016 |
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas. |
PIM1 |
| 48 |
27198204 |
10.1038/leu.2016.135 |
2016 |
Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis. |
PIM1 |
| 49 |
25189415 |
10.1038/leu.2014.264 |
2015 |
The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing. |
PIM1 |
| 50 |
24240734 |
10.1007/s00401-013-1202-x |
2014 |
Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice. |
PIM1 |
| 51 |
24970810 |
10.18632/oncotarget.2080 |
2014 |
Mutational analysis of primary central nervous system lymphoma. |
PIM1 |
| 52 |
22451912 |
10.1073/pnas.1201168109 |
2012 |
PIM1 gene cooperates with human BCL6 gene to promote the development of lymphomas. |
PIM1 |
| 53 |
22722314 |
10.1038/bjc.2012.272 |
2012 |
PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma. |
PIM1 |
| 54 |
19336552 |
10.1158/1055-9965.EPI-08-1037 |
2009 |
Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. |
PIM1 |
| 55 |
19573080 |
10.1111/j.1365-2141.2009.07790.x |
2009 |
Common genetic variants in candidate genes and risk of familial lymphoid malignancies. |
PIM1 |
| 56 |
19773279 |
10.1136/oem.2008.044024 |
2009 |
Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. |
PIM1 |
| 57 |
16373702 |
10.1158/1535-7163.MCT-05-0146 |
2005 |
Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures. |
PIM1 |
| 58 |
12472567 |
10.1046/j.1365-2141.2002.03931.x |
2002 |
Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma. |
PIM1 |
Datasets
Models
